Dexcom welcomed the advocates to a photoshoot in Los Angeles that included Grammy-nominated artist, actor, producer and ...

Aristotle Atlantic Partners, LLC, an investment advisor, released its “Core Equity Strategy” third-quarter 2025 investor ...

Although DexCom stock has trailed the broader market over the past year, analysts remain bullish about its prospects.

Looking back on patient monitoring stocks’ Q3 earnings, we examine this quarter’s best and worst performers, including DexCom ...

DexCom's growth rate has been improving, but that hasn't been enough of a reason for investors to buy up the stock.

The global patient monitoring devices market size is expected to reach USD 118.21 billion by 2033, registering a CAGR of 10.21% from 2025 to 2033, according to a new report by Grand View Research, Inc ...

Tandem Diabetes Care, Inc. (Nasdaq: TNDM), a global insulin delivery and diabetes technology company, today announced that the U.S. Food and Drug Administration (FDA) has cleared the Android version ...

BOSTON, Oct. 31, 2025 /PRNewswire/ -- Elevaris Medical Devices, a Contract Development and Manufacturing Organization for industry-leading multi-national healthcare companies, announced the ...

RBC Capital lowered the firm’s price target on DexCom (DXCM) to $85 from $100 but keeps an Outperform rating on the shares. The market misunderstood the conservative initial 2026 guide, which likely ...

Javascript must be enabled to use this site. Please enable Javascript in your browser and try again. Life’s better together. That’s why AARP brings free events ...

Why: Rosen Law Firm, a global investor rights law firm, announces the filing of a class action lawsuit on behalf of purchasers of securities of DexCom, Inc. (NASDAQ: DXCM) between July 26, 2024 and ...

Microsoft has said the idea of a video game exclusive locked to a single storefront has become “antiquated for most people,” as the company soldiers on with its multiplatform push for Xbox games. Xbox ...